Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)

SHE:002872 Revenue

Tiansheng Pharmaceutical Group had revenue of 131.96M CNY in the quarter ending March 31, 2026, with 14.22% growth. This brings the company's revenue in the last twelve months to 530.52M, down -1.25% year-over-year. In the year 2025, Tiansheng Pharmaceutical Group had annual revenue of 514.09M, down -9.76%.

• Revenue (ttm): 530.52M
• Revenue Growth: -1.25%
• P/S Ratio: 2.90
• Revenue / Employee: 416.75K
• Employees: 1,272
• Market Cap: 1.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	514.09M	-55.63M	-9.76%
Dec 31, 2024	569.71M	-9.62M	-1.66%
Dec 31, 2023	579.33M	-27.66M	-4.56%
Jan 1, 2023	606.99M	-129.69M	-17.61%
Jan 1, 2022	736.69M	-466.06M	-38.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error